Emerging roles of mitochondria ROS in atherosclerotic lesions: Causation or association?

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 5, 2014, Pages 381-390

  Wang, Ying ^a   Tabas, Ira ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Antioxidant therapy; Atherosclerosis; Inflammation; Macrophage; Mitochondrial ROS

Indexed keywords

ANGIOTENSIN II; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MITOFUSIN 1; MITOFUSIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 7; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2; ANTIOXIDANT;

ARTERIAL WALL THICKNESS; ARTERY LESION; ATHEROSCLEROSIS; ATHEROSCLEROTIC LESION; CELL PROLIFERATION; DNA REPAIR; HEMODIALYSIS; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; MACROAUTOPHAGY; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL FISSION; MITOCHONDRIAL FUSION; MITOCHONDRION; MITOPHAGY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; REVIEW; SMOKING; SMOOTH MUSCLE FIBER; ANIMAL; METABOLISM; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84901483040     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.23929     Document Type: Review

References (81)

1. Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol, 2003; 552: 335-344.
2. Ali MH, Mungai PT, Schumacker PT: Stretch-induced phosphorylation of focal adhesion kinase in endothelial cells: Role of mitochondrial oxidants. Am J Physiol Lung Cell Mol Physiol, 2006; 291: L38-45.
3. Zhang DX, Gutterman DD: Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol, 2007; 292: H2023-2031.
4. Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD: Mitochondrial sources of h2o2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res, 2003; 93: 573-580.
5. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS: Extension of murine life span by overexpression of catalase targeted to mitochondria. Science, 2005; 308: 1909-1911.
6. Mao P, Manczak M, Calkins MJ, Truong Q, Reddy TP, Reddy AP, Shirendeb U, Lo HH, Rabinovitch PS, Reddy PH: Mitochondria-targeted catalase reduces abnormal app processing, amyloid beta production and bace1 in a mouse model of alzheimer's disease: Implications for neuroprotection and lifespan extension. Hum Mol Genet, 2012; 21: 2973-2990.
7. Dai DF, Hsieh EJ, Liu Y, Chen T, Beyer RP, Chin MT, MacCoss MJ, Rabinovitch PS: Mitochondrial proteome remodelling in pressure overload-induced heart failure: The role of mitochondrial oxidative stress. Cardiovasc Res, 2012; 93: 79-88.
8. Ignarro LJ, Kadowitz PJ: The pharmacological and physiological role of cyclic gmp in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol, 1985; 25: 171-191.
9. Bohr VA, Anson RM: Mitochondrial DNA repair pathways. J Bioenerg Biomembr, 1999; 31: 391-398.
10. Dalfino G, Simone S, Porreca S, Cosola C, Balestra C, Manno C, Schena FP, Grandaliano G, Pertosa G: Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease. Atherosclerosis, 2010; 211: 418-423.
11. de Souza-Pinto NC, Hogue BA, Bohr VA: DNA repair and aging in mouse liver: 8-oxodg glycosylase activity increase in mitochondrial but not in nuclear extracts. Free Radic Biol Med, 2001; 30: 916-923.
12. Ari E, Kaya Y, Demir H, Cebi A, Alp HH, Bakan E, Odabasi D, Keskin S: Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients. Hemodial Int, 2011; 15: 453-459.
13. Morita M, Yano S, Yamaguchi T, Sugimoto T: Advanced glycation end products-induced reactive oxygen species generation is partly through nf-kappa b activation in human aortic endothelial cells. J Diabetes Complications, 2013; 27: 11-15.
14. Wang Y, Wang GZ, Rabinovitch P, Tabas I: Macrophage mitochondrial oxidative stress promotes atherosclerosis and nf-kb-mediated inflammation in macrophages. Circ Res, 2013.
15. Ling WH, Wang LL, Ma J: Supplementation of the black rice outer layer fraction to rabbits decreases atherosclerotic plaque formation and increases antioxidant status. J Nutr, 2002; 132: 20-26.
16. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K, Runge MS: Mitochondrial integrity and function in atherogenesis. Circulation, 2002; 106: 544-549.
17. Tuominen A, Miller YI, Hansen LF, Kesaniemi YA, Witztum JL, Horkko S: A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2006; 26: 2096-2102.
18. Perrotta I, Perrotta E, Sesti S, Cassese M, Mazzulla S: Mnsod expression in human atherosclerotic plaques: An immunohistochemical and ultrastructural study. Cardiovasc Pathol, 2013.
19. Cho YE, Basu A, Dai A, Heldak M, Makino A: Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice. Am J Physiol Cell Physiol, 2013; 305: C1033-1040.
20. t Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, Twisk J: Aorta of apoe-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res, 2003; 93: 262-269.
21. Harrison CM, Pompilius M, Pinkerton KE, Ballinger SW: Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production. Environ Health Perspect, 2011; 119: 676-681.
22. Navarro-Antolin J, Redondo-Horcajo M, Zaragoza C, Alvarez-Barrientos A, Fernandez AP, Leon-Gomez E, Rodrigo J, Lamas S: Role of peroxynitrite in endothelial damage mediated by cyclosporine a. Free Radic Biol Med, 2007; 42: 394-403.
23. Torzewski M, Ochsenhirt V, Kleschyov AL, Oelze M, Daiber A, Li H, Rossmann H, Tsimikas S, Reifenberg K, Cheng F, Lehr HA, Blankenberg S, Forstermann U, Munzel T, Lackner KJ: Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol, 2007; 27: 850-857.
24. Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB: Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein e-deficient mice. Circulation, 2007; 115: 2178-2187.
25. Myung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK, Park BJ, Korean Meta-Analysis Study G: Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: Systematic review and meta-analysis of randomised controlled trials. BMJ, 2013; 346: f10.
26. Yang H, Roberts LJ, Shi MJ, Zhou LC, Ballard BR, Richardson A, Guo ZM: Retardation of atherosclerosis by overexpression of catalase or both cu/zn-superoxide dismutase and catalase in mice lacking apolipoprotein e. Circ Res, 2004; 95: 1075-1081.
27. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS: P47phox is required for atherosclerotic lesion progression in apoe(-/-) mice. J Clin Invest, 2001; 108: 1513-1522.
28. Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K, Investigators S: Effects of ramipril and vitamin e on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin e (secure). Circulation, 2001; 103: 919-925.
29. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R: Lack of effect of longterm supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med, 1996; 334: 1145-1149.
30. Madamanchi NR, Moon SK, Hakim ZS, Clark S, Mehrizi A, Patterson C, Runge MS: Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms. Arterioscler Thromb Vasc Biol, 2005; 25: 950-956.
31. Kubli DA, Gustafsson AB: Mitochondria and mitophagy: The yin and yang of cell death control. Circ Res, 2012; 111: 1208-1221.
32. Wang Y, Nartiss Y, Steipe B, McQuibban GA, Kim PK: Ros-induced mitochondrial depolarization initiates park2/ parkin-dependent mitochondrial degradation by autophagy. Autophagy, 2012; 8: 1462-1476.
33. Kim I, Rodriguez-Enriquez S, Lemasters JJ: Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys, 2007; 462: 245-253.
34. Wong ES, Tan JM, Wang C, Zhang Z, Tay SP, Zaiden N, Ko HS, Dawson VL, Dawson TM, Lim KL: Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations. J Biol Chem, 2007; 282: 12310-12318.
35. Winklhofer KF, Henn IH, Kay-Jackson PC, Heller U, Tatzelt J: Inactivation of parkin by oxidative stress and c-terminal truncations: A protective role of molecular chaperones. J Biol Chem, 2003; 278: 47199-47208.
36. Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, Ting JP, Virgin HW, Kastan MB, Semenkovich CF: Autophagy links inflammasomes to atherosclerotic progression. Cell Metab, 2012; 15: 534-544.
37. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J, Tabas I: Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab, 2012; 15: 545-553.
38. Zhou R, Yazdi AS, Menu P, Tschopp J: A role for mitochondria in nlrp3 inflammasome activation. Nature, 2011; 469: 221-225.
39. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, Rentsendorj A, Vargas M, Guerrero C, Wang Y, Fitzgerald KA, Underhill DM, Town T, Arditi M: Oxidized mitochondrial DNA activates the nlrp3 inflammasome during apoptosis. Immunity, 2012; 36: 401-414.
40. Zinkevich NS, Gutterman DD: Ros-induced ros release in vascular biology: Redox-redox signaling. Am J Physiol Heart Circ Physiol, 2011; 301: H647-653.
41. Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassegue B, Griendling KK, Harrison DG, Dikalova AE: Nox2-induced production of mitochondrial superoxide in angiotensin ii-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal, 2013.
42. Jornot L, Maechler P, Wollheim CB, Junod AF: Reactive oxygen metabolites increase mitochondrial calcium in endothelial cells: Implication of the ca2+/na+ exchanger. J Cell Sci, 1999; 112 (Pt 7): 1013-1022.
43. Ramachandran A, Levonen AL, Brookes PS, Ceaser E, Shiva S, Barone MC, Darley-Usmar V: Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic Biol Med, 2002; 33: 1465-1474.
44. Castillo EF, Dekonenko A, Arko-Mensah J, Mandell MA, Dupont N, Jiang S, Delgado-Vargas M, Timmins GS, Bhattacharya D, Yang H, Hutt J, Lyons CR, Dobos KM, Deretic V: Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc Natl Acad Sci U S A, 2012; 109: E3168-3176.
45. Ding Z, Liu S, Wang X, Khaidakov M, Dai Y, Mehta JL: Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep, 2013; 3: 1077.
46. Archer SL: Mitochondrial dynamics--mitochondrial fission and fusion in human diseases. N Engl J Med, 2013; 369: 2236-2251.
47. Brooks C, Wei Q, Cho SG, Dong Z: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest, 2009; 119: 1275-1285.
48. Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ: Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation, 2010; 121: 2012-2022.
49. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F: Mechanisms of disease: Pulmonary arterial hypertension. Nat Rev Cardiol, 2011; 8: 443-455.
50. Zorzano A, Liesa M, Palacin M: Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol, 2009; 41: 1846-1854.
51. Wang H, Song P, Du L, Tian W, Yue W, Liu M, Li D, Wang B, Zhu Y, Cao C, Zhou J, Chen Q: Parkin ubiquitinates drp1 for proteasome-dependent degradation: Implication of dysregulated mitochondrial dynamics in parkinson disease. J Biol Chem, 2011; 286: 11649-11658.
52. Marsboom G, Toth PT, Ryan JJ, Hong Z, Wu X, Fang YH, Thenappan T, Piao L, Zhang HJ, Pogoriler J, Chen Y, Morrow E, Weir EK, Rehman J, Archer SL: Dynaminrelated protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension. Circ Res, 2012; 110: 1484-1497.
53. Ryan JJ, Marsboom G, Fang YH, Toth PT, Morrow E, Luo N, Piao L, Hong Z, Ericson K, Zhang HJ, Han M, Haney CR, Chen CT, Sharp WW, Archer SL: Pgc1alphamediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. Am J Respir Crit Care Med, 2013; 187: 865-878.
54. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP, Tang J: Dysregulation of hsg triggers vascular proliferative disorders. Nat Cell Biol, 2004; 6: 872-883.
55. Guo YH, Chen K, Gao W, Li Q, Chen L, Wang GS, Tang J: Overexpression of mitofusin 2 inhibited oxidized lowdensity lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. Biochem Biophys Res Commun, 2007; 363: 411-417.
56. Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, Hamburg NM, Frame AA, Caiano TL, Kluge MA, Duess MA, Levit A, Kim B, Hartman ML, Joseph L, Shirihai OS, Vita JA: Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation, 2011; 124: 444-453.
57. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W: A common polymorphism in the promoter of ucp2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet, 2001; 28: 178-183.
58. Oberkofler H, Iglseder B, Klein K, Unger J, Haltmayer M, Krempler F, Paulweber B, Patsch W: Associations of the ucp2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol, 2005; 25: 604-610.
59. Krempler F, Esterbauer H, Weitgasser R, Ebenbichler C, Patsch JR, Miller K, Xie M, Linnemayr V, Oberkofler H, Patsch W: A functional polymorphism in the promoter of ucp2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes, 2002; 51: 3331-3335.
60. Dhamrait SS, Stephens JW, Cooper JA, Acharya J, Mani AR, Moore K, Miller GJ, Humphries SE, Hurel SJ, Montgomery HE: Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur Heart J, 2004; 25: 468-475.
61. Moukdar F, Robidoux J, Lyght O, Pi J, Daniel KW, Collins S: Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice. J Lipid Res, 2009; 50: 59-70.
62. Blanc J, Alves-Guerra MC, Esposito B, Rousset S, Gourdy P, Ricquier D, Tedgui A, Miroux B, Mallat Z: Protective role of uncoupling protein 2 in atherosclerosis. Circulation, 2003; 107: 388-390.
63. Lee KU, Lee IK, Han J, Song DK, Kim YM, Song HS, Kim HS, Lee WJ, Koh EH, Song KH, Han SM, Kim MS, Park IS, Park JY: Effects of recombinant adenovirusmediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res, 2005; 96: 1200-1207.
64. Tian XY, Wong WT, Xu A, Lu Y, Zhang Y, Wang L, Cheang WS, Wang Y, Yao X, Huang Y: Uncoupling protein-2 protects endothelial function in diet-induced obese mice. Circ Res, 2012; 110: 1211-1216.
65. Ryu JW, Hong KH, Maeng JH, Kim JB, Ko J, Park JY, Lee KU, Hong MK, Park SW, Kim YH, Han KH: Overexpression of uncoupling protein 2 in thp1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler Thromb Vasc Biol, 2004; 24: 864-870.
66. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA, Harper JA, Roebuck SJ, Morrison A, Pickering S, Clapham JC, Brand MD: Superoxide activates mitochondrial uncoupling proteins. Nature, 2002; 415: 96-99.
67. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, Akira S, Yamamoto A, Komuro I, Otsu K: Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature, 2012; 485: 251-255.
68. Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, Otterbein LE, Hauser CJ, Itagaki K: Mitochondrial damps increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One, 2013; 8: e59989.
69. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E: Nlrp3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 2010; 464: 1357-1361.
70. Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, Stuart LM, Latz E, Fitzgerald KA, Moore KJ: Cd36 coordinates nlrp3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol, 2013; 14: 812-820.
71. Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang WC, Marin T, Shentu TP, Wen L, Gongol B, Sun W, Liang X, Chen J, Huang HD, Pedra JH, Johnson DA, Shyy JY: Sterol regulatory element binding protein 2 activation of nlrp3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation, 2013; 128: 632-642.
72. Sobenin IA, Sazonova MA, Postnov AY, Bobryshev YV, Orekhov AN: Mitochondrial mutations are associated with atherosclerotic lesions in the human aorta. Clin Dev Immunol, 2012; 2012: 83-2464.
73. Chien MC, Huang WT, Wang PW, Liou CW, Lin TK, Hsieh CJ, Weng SW: Role of mitochondrial DNA variants and copy number in diabetic atherogenesis. Genet Mol Res, 2012; 11: 3339-3348.
74. Mercer JR, Cheng KK, Figg N, Gorenne I, Mahmoudi M, Griffin J, Vidal-Puig A, Logan A, Murphy MP, Bennett M: DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res, 2010; 107: 1021-1031.
75. Yu E, Calvert PA, Mercer JR, Harrison J, Baker L, Figg NL, Kumar S, Wang JC, Hurst LA, Obaid DR, Logan A, West NE, Clarke MC, Vidal-Puig A, Murphy MP, Bennett MR: Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation. 2013; 128: 702-712.
76. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge MS: Hydrogen peroxide-and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res, 2000; 86: 960-966.
77. Esposti MD: Lipids, cardiolipin and apoptosis: A greasy licence to kill. Cell Death Differ, 2002; 9: 234-236.
78. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR: Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994; 375: 81-88.
79. Hazen SL, Heinecke JW: 3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest, 1997; 99: 2075-2081.
80. van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Luscher TF: Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med, 2000; 192: 1731-1744.
81. Davis CW, Hawkins BJ, Ramasamy S, Irrinki KM, Cameron BA, Islam K, Daswani VP, Doonan PJ, Manevich Y, Madesh M: Nitration of the mitochondrial complex i subunit ndufb8 elicits rip1-and rip3-mediated necrosis. Free Radic Biol Med, 2010; 48: 306-317